Research ArticleClinical Studies

Phase II Randomized Study of Interleukin-2 with or without 13-cis Retinoic Acid as Maintenance Therapy in Patients with Advanced Cancer Responsive to Chemotherapy

FRANCESCO RECCHIA, GAETANO SAGGIO, ALISIA CESTA, EDOARDO ALESSE, RITA GALLO, STEFANO NECOZIONE and SILVIO REA
Anticancer Research July 2005, 25 (4) 3149-3157;

Article Information

vol. 25 no. 4 3149-3157
PubMed 
16080579
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received January 11, 2005
  • Accepted May 6, 2005
  • Published online July 1, 2005.
Copyright & Usage 
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. FRANCESCO RECCHIA1,2,
  2. GAETANO SAGGIO1,
  3. ALISIA CESTA1,
  4. EDOARDO ALESSE3,
  5. RITA GALLO3,
  6. STEFANO NECOZIONE4 and
  7. SILVIO REA2,5
  1. 1Unità operativa di Oncologia, Ospedale Civile di Avezzano
  2. 2Fondazione “Carlo Ferri”, Monterotondo
  3. 3Dipartimento di Medicina Sperimentale
  4. 4Epidemiologia Clinica e, Università degli Studi de L'Aquila, Italy
  5. 5Oncologia Chirurgica, Università degli Studi de L'Aquila, Italy
  1. Correspondence to: Francesco Recchia, MD, Via Rossetti 1, 67056 Luco dei Marsi (AQ), Italy. Tel: 0863-499250, Fax: 0863-499388, e-mail: frecchia1946{at}libero.it

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Phase II Randomized Study of Interleukin-2 with or without 13-cis Retinoic Acid as Maintenance Therapy in Patients with Advanced Cancer Responsive to Chemotherapy
FRANCESCO RECCHIA, GAETANO SAGGIO, ALISIA CESTA, EDOARDO ALESSE, RITA GALLO, STEFANO NECOZIONE, SILVIO REA
Anticancer Research Jul 2005, 25 (4) 3149-3157;
Twitter logo Facebook logo Mendeley logo

Jump to section